Should the MATCH results be extrapolated to all stroke patients and affect ongoing trials evaluating clopidogrel plus aspirin?
Department of Neurology and Stroke Centre, Bichat Hospital and Medical School, 46 rue Henri Huchard, Paris, France 75018. amarenco@ccr.jussieu.fr
Pierre
P
Amarenco
Geoffrey A
GA
Donnan
D001241:Aspirin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin